Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 614 of 745

Advanced search

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Medicare's GLP-1 Bridge and what's next for biotech (LLY:NYSE)

Seeking AlphaOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Teva Launches Hydrogen Truck for Pharmaceutical Logistics

Fuel Cells WorksOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

FDA Recalls and Warnings: Foreign Substance Found in Millions of Steroid Eye Drops, Seizure Drug Mix-Up & More

MedShadow FoundationOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

QuantumCell commits $2.2bn on AlzeCure’s Alzheimer’s platform

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 1Devicespresspart.comTier 1 · Company source

PFAS-free coatings for MDI canisters: What to look for

H&T PresspartOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Bristol-Myers Squibb Hires Lobbyist on Drug Pricing

Legis1Original source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Postpartum reintegration: an uncomfortable silence pharmacy can no longer afford

The Pharmaceutical JournalOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Welgene Biotech Co., Ltd. – TPEX:6661

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

PharmTech.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why

Yahoo FinanceOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Biotechs ‘in better position to avoid workforce reductions’ as layoffs continue to ease in Q2’26

Fierce BiotechOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS

Pharmaceutical ExecutiveOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal

BioPharma DiveOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

What's Really Driving the Direct-to-Patient Boom?

Pharmaceutical CommerceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

US judge pauses Louisiana’s challenge to FDA abortion drug rule

93.3 The DriveOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

One step closer: FDA removes prohibitions on drug testing devices; BUILD America 250 pushes hair testing

TheTrucker.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why

Zacks Investment ResearchOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Sarepta announces FDA acceptance of sNDAs for Duchenne muscular dystrophy drugs

PharmaLiveOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Anthropic launches AI initiative for life sciences

medwatch.comOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

More signs that GLP-1s may help with peripheral artery disease

statnews.comOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Angitia ends Phase 3 in disc disease; Abivax targets $800M on colitis data

Endpoints NewsOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Surge in RMAT designations awarded by the FDA

Pharmaceutical TechnologyOriginal source

🇪🇺Jul 1Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: CLINICCARDS: Voxel-Based AI for 3D Dental Diagnostics

CORDISOriginal source

🇪🇺Jul 1Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Precision biochemistry for women’s health - the first dual self-test for accurate at-home detection of bacterial vaginosis and vulvovaginal candidiasis

CORDISOriginal source

🇪🇺Jul 1Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Exploring Extended Field-of-view PET for precision medicine

CORDISOriginal source

🇪🇺Jul 1Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: A Multi-stage Malaria Vaccine for Control and Elimination

CORDISOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Prague: The up-and-coming biotech hub in Central Europe

Labiotech.euOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Cholesterol and Heart Medications Were Recalled Early This Year — Here Is What Statin Users Should Check

inklOriginal source

🇺🇰Jul 1Researchmed.cam.ac.ukTier 2 · Direct publisher

COVID-19 vaccine boosters may help protect against future animal coronaviruses

University of Cambridge - Clinical Medicine NewsOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Biotech Startup Turns to Space to Manufacture Artificial Retinas for Treating Blindness

Yahoo FinanceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Amgen or Biogen: Which Biotech Stock Appears Better Poised?

Zacks Investment ResearchOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Eli Lilly’s $40M Bet on AI-Designed Injectable Antibody Sparks 36% Rally

BitgetOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Duloxetine (Generic Cymbalta) Recalled Over Potential Cancer-Causing Compound: Here Are the Lot Numbers to Check

Medical DailyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Duloxetine (Generic Cymbalta) Recalled Over Potential…

inklOriginal source

🇺🇸Jul 1Industryinvestors.amneal.comTier 1 · Company source

Amneal’s New U.S. Sterile Manufacturing Facility Selected for FDA PreCheck Pilot Program

Amneal Pharmaceuticals RSSOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Abivax's Ulcerative Colitis Drug Clears Safety Hurdle, Stock Surges Nearly 40% to Recover Losses

finance.biggo.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Reliability Determines Success in the Biotech Industry

inc.comOriginal source

🇩🇰Jul 1Associationnovonordiskfonden.dkTier 2 · Direct publisher

Quantum: A risk worth taking

Novo Nordisk Foundation (News)Original source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Ipsen gets the Memo, penning €700M deal to buy rare disease biotech for clinical-stage asset

Fierce BiotechOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail

BioSpaceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Tavneos Recall Pressure Mounts, As EU Joins FDA Seeking Market Removal

AboutLawsuits.comOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

Vaccine update: issue 372, June 2026, MenB special

Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.

UK Health Security AgencyOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

FDA approves Orca Bio’s T cell therapy for blood cancer patients

statnews.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Harpreet Singh: Supporting Biotech Through Clinical and Regulatory Strategy

OncodailyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

While You Watched Chips, Biotech Nearly Doubled — Here's Why

MoomooOriginal source

🌍Jul 1Regulatoryravimiamet.eeTier 1 · Regulatory source

New Medical Devices and Appliances Database (EMDDB) launches next week

SAM EstoniaOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown

Pharmaceutical TechnologyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Lonza expands manufacturing capacity for HPAPI and ADC payload-linkers

European Pharmaceutical ReviewOriginal source

🇿🇦Jul 1Researchsu.ac.zaTier 3 · Secondary coverage

Prof Mesias Alfeus’s vision brings global finance congress to Africa

Stellenbosch UniversityOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Telum raises 18 million euros for hospital pneumonia program

The Pharma LetterOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

AlzeCure lands $2.2 billion NeuroRestore licensing deal

The Pharma LetterOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

New drug data makes this French biotech stock a buy, says Jefferies

CNBCOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Lilly and Regeneron amongst first incumbents to FDA’s fast-track facility scheme

Pharmaceutical TechnologyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Goldenwell Biotech (GWLL) Q1 2026 shows loss and going concern warning

Stock TitanOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Goldenwell Biotech (OTCQB: GWLL) flags going concern risk in 2025

Stock TitanOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable Demand - Has The Bull Case Changed?

Yahoo FinanceOriginal source

🌍Jul 1Mediacentogene.comTier 2 · Direct publisher

CENTOGENE APAC Office Official Opening Ceremony in Taiwan

CentogeneOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch

Applied Clinical Trials OnlineOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

GOLDENWELL BIOTECH, INC. FY 2025: Revenue $55 Net loss $296471 EPS $(2.99) — 10-K Summary

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

GOLDENWELL BIOTECH, INC. 1Q 2026: Revenue $0 EPS $(0.00018) — 10-Q Summary

TradingViewOriginal source